Abstract

Herein, a novel chitosan derivative nanoparticle was proposed to function as a delivery carrier. First of all, an improvement was made to the way N-2-hydroxypropyl trimcthyl ammonium chloride chitosan (N-2-HACC) was synthesized. Moreover, the solution to one-step synthesis of N-2-HACC from chitosan (CS) was developed. Different from the previous report, the synthesis process was simplified, and there was a reduction in the amount of 2,3-epoxypropyl trimethyl ammonium chloride (EPTAC) used. With its excellent water solubility maintained, the relatively low degree of substitution was controlled to facilitate the cross-linking reaction. The results obtained from 1H-NMR, FTIR spectroscopy, and XRD indicated a smooth EPTAC onto CS for the formation of N-2-HACC with 59.33% the degree of substitution (DS). According to our results, N-2-HACC could be dissolved in various organic solvents, deionized water, 1% acetic acid aqueous solution, and others at room temperature. Finally, a novel chitosan nanoparticle material was prepared using the self-assembly method with β-glycerophosphate sodium (β-GC), with excellent immune properties achieved, thus providing a new strategy for chitosan self-assembled nanoparticles.

Highlights

  • Porcine epidemic diarrhea virus (PED) is a pig infectious disease caused by porcine epidemic diarrhea virus (PEDV), causing in particular a large number of death of piglets [1]

  • The N-2-HACC showed excellent solubility and the capability to reduce the degree of substitution

  • It simplified the process of N-2-HACC synthesis and reduced the number of rea

Read more

Summary

Introduction

Porcine epidemic diarrhea virus (PED) is a pig infectious disease caused by porcine epidemic diarrhea virus (PEDV), causing in particular a large number of death of piglets [1]. PEDV is transmitted by infecting porcine epithelial cells through the fecal–oral route [2]. Vaccine is an important way to prevent this disease [3]. An ideal vaccine is supposed to induce mucosal immune responses. Existing vaccines are ineffective in the control and prevention of PEDV, which makes it necessary to develop high-efficiency vaccines. Especially nanoparticles of chitosan (CS) and its derivatives, as vaccine adjuvants are the focus of current research [5]. The nanoparticles of chitosan (CS) and its derivative can induce mucosal immune response, as confirmed in those relevant reports. The nanoparticles of chitosan (CS) and its derivative can induce mucosal immune response, as confirmed in those relevant reports. [6,7]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.